Bexlosteride

Description: Bexlosteride (LY300502), a benzoquinolinone derivative, functions as a human type I 5alpha-reductase inhibitor. It demonstrates metabolic inhibition, antiproliferative, and antisecretory activities specifically in LNCaP human prostatic adenocarcinoma cell cultures, positioning it as a potent agent for prostate cancer research [1] [2]. Target: Others. Smiles: CN1[C@]2([C@@](C=3C(CC2)=CC(Cl)=CC3)(CCC1=O)[H])[H]